TRIBOR STUDY Randomized, double-blind, placebo-controlled, cross-over study on the safety and efficacy of tiotropium in children with bronchopulmonary dysplasia - Amsterdam 2025

Emerging evidence in paediatric rare lung and airway disease

Chair(s): Raffaella Nenna, Uros Krivec

Session type: Oral presentation

TRIBOR STUDY Randomized, double-blind, placebo-controlled, cross-over study on the safety and efficacy of tiotropium in children with bronchopulmonary dysplasia

Burak Uslu

EVENTS HOME

Previous presentation

Next presentation

Session content

Advances in PCD gene diagnostics: new initiatives to improve gene-variant-disease relationships

Mafalda De Almeida Gomes

Replay

Poster

Abstract

Slides

The site and nature of large and small airway remodeling in human end-stage primary ciliary dyskinesia lungs

Astrid Vermaut

Replay

Poster

Abstract

Slides

Effect of Air Pollution on Pulmonary Function in Patients with Primary Ciliary Dyskinesia

Ayyüce Ünlü

Replay

Poster

Abstract

Slides

New insights in post-infectious bronchiolitis obliterans: the French RespiRare cohort

Julie Mazenq

Replay

Poster

Abstract

Slides

Repurposing CFTR modulators in ABCA3-associated interstitial lung disease: a therapeutic option? A CRC chILDEU study

Nadia Nathan

Replay

Poster

Abstract

Slides

TRIBOR STUDY Randomized, double-blind, placebo-controlled, cross-over study on the safety and efficacy of tiotropium in children with bronchopulmonary dysplasia

Burak Uslu

Replay

Abstract

Slides

Lung function trajectories in childhood interstitial lung disease (chILD)

Simone Hashimoto

Replay

Abstract

Slides

Long-term outcomes of persistent tachypnoea of infancy/neuroendocrine cell hyperplasia of infancy: study of the CRC chILD-EU

Honorata Marczak

Replay

Poster

Abstract

Slides

Safety and diagnostic yield of transbronchial cryobiopsy in children a prospective single-centre observational study

Pia Maier

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}